Response to Sumatriptan in Headache of MELAS Syndrome
Neurol 61:577-578, Iizuka,T.,et al, 2003
Complementary/Alternative Medicine for Epilepsy in Arizona
Neurol 61:576-577, Sirven,J.I.,et al, 2003
Oral Contraceptives Reduce Lamotrigine Plasma Levels
Neurol 61:570-571, Sabers,A.,et al, 2003
Lupus and Zoster
Lancet 362:616, Douglas,K.M.J., 2003
A Risk Score for Predicting Stroke or Death in Individuals with New-Onset Atrial Fibrillation in the Community
JAMA 290:1049-1056,1093, Wang,T.J.,et al, 2003
Stroke Prevention in Atrial Fibrillation
JAMA 290:1093-1095, Waldo,A.L., 2003
Psychiatric Adverse Events During Levetiracetam Therapy
Neurol 61:704-706, Mula,M.,et al, 2003
Seizure Remission and Antiepileptic Drug Discontinuation in Children with Tuberous Sclerosis Complex
Arch Neurol 60:1286-1289, Sparagana,S.P.,et al, 2003
Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation
NEJM 349:1019-1026, Hylek,E.M.,et al, 2003
Should I Start All My Ischaemic Stroke and TIA Patients on a Statin, an ACE Inhibitor, a Diuretic, and Aspirin Today?
JNNP 74:1461-1464, Sandercock,P.A.G., 2003
Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events
Stroke 34:2741-2749, Rashid,P.,et al, 2003
Randomized, Concentration-Controlled Trial of Topiramate in Refractory Focal Epilepsy
Neurol 61:1210-1218, Christensen,J.,et al, 2003
Discontinuation of Levetiracetam Because of Behavioral Side Effects
Neurol 61:1218-1221, White,J.R.,et al, 2003
Dietary Antioxidants and the Risk of Ischemic Stroke
Neurol 61:1273-1275, Voko,Z.,et al, 2003
Mechanisms of Stroke Protection by Physical Activity
Ann Neurol 54:582-590, Endres,M.,et al, 2003
Drug Points
BJM 327:905, Hadjikoutis,S.,et al, 2003
Stroke
Lancet 362:1211-1224, Warlow,C.,et al, 2003
Clinical Importance of Neutralising Antibodies Against Interferon Beta in Patients with Relapsing-Remitting Multiple Sclerosis
Lancet 362:1184-1191, Sorensen,P.S.,et al, 2003
Sensorineural Hearing Loss: A Reversible Effect of Vigabatrin
Neurol 61:1020-1021, Papdeas,E.,et al, 2003
Hemispherectomy for Intractable Unihemispheric Epilepsy
Neurol 61:887-890, Kossoff,E.H.,et al, 2003
Physical Activity and Stroke Risk
Stroke 34:2475-2482, Lee,C.D.,et al, 2003
Acute Myopia and Angle-Closure Glaucoma Induced by Topiramate
Neurol 61:1306, Boentert,M.,et al, 2003
Can We Prevent Cerebral Palsy?
NEJM 349:1765-1769, Nelson,K.B., 2003
A 50-Year-Old Woman With Atrial Fibrillation
JAMA 290:2182-2189, Singer,D.E., 2003
Seizure Exacerbation Associated with Oxcarbazepine in Idiopathic Focal Epilepsy of Childhood
Neurol 61:1012-1013, Chapman,K.,et al, 2003
Association Between Migraine and Celiac Disease: Results From a Preliminary Case-Control and Therapeutic Study
, Gabrielli, M.,et al, 2003
Resolution of Severe Paraplegia Due to Aortic Dissection After CSF Drainage
Neurol 61:142-143, Blacker,D.J., et al, 2003
Laughing Headache: A Novel Type of Triggered Headache with Response to Divalproex Sodium
Headache 43:801-803, Levin,M. &Ward,T.N., 2003
Mitoxantrone in Progressive Multiple Sclerosis: A Placebo-Controlled, Double-Blind, Randomised, Multicentre Trial
Lancet 360:2018-2025, Hartung,H.,et al, 2002
Copaxone's Effect on MRI-Monitored Disease in Relapsing MS is Reproducible and Sustained
Neurol 59:1284-1286, Wolinsky,J.S.,et al, 2002
Immunization and MS
Neurol 59:1837-1843, Rutschmann,O.T.,et al, 2002
Migraine--Current Understanding and Treatment
NEJM 346:257-270, Goadsby,P.J.,et al, 2002
Benefit of Atrial Pacing in Sleep Apnea Syndrome
NEJM 346:404-412,390,444, Garrigue,S., et al, 2002
Alcohol Consumption and Risk of Dementia: the Rotterdam Study
Lancet 359:281-286, Ruitenberg,A.,et al, 2002
Poststroke Seizures
Arch Neurol 59:195-202, Silverman,I.E.,et al, 2002
Refractory Status Epilepticus
Arch Neurol 59:205-210,188, Mayer,S.A.,et al, 2002
Quality of Life, Anxiety, and Depression in Patients With an Untreated Intracranial Aneurysm or Arteriovenous Malformation
Stroke 33:440-443, van der Schaaf,I.C.,et al, 2002
Association Between Influenza Vaccination and Reduced Risk of Brain Infarction
Stroke 33:513-518, LavalTe,P.,et al, 2002
Physician Advice, Patient Actions, and Health-Related Quality of Life in Secondary Prevention of Stroke Through Diet and Exercise
Stroke 33:565-571,570, Greenlund,K.J.,et al, 2002
An Open-Label Trial of Combination Therapy With Interferon B-1a and Oral Methotrexate in MS
Neurol 58:314-317, Calabresi,P.A.,et al, 2002
Disease Modifying Therapies in Multiple Sclerosis
Neurol 58:169-178, Goodin,D.S.,et al, 2002
Chronic Diarrhea Associated with Vagal Nerve Stimulation
Neurol 58:330, Sanossian,N. &Haut,S., 2002
A Longitudinal Study of Abnormalities on MRI and Disability From Multiple Sclerosis
NEJM 346:158-164,199, Brex,P.A.,et al, 2002
The PROGRESS Trial: Preventing Strokes by Lowering Blood Pressure in Patients With Cerebral Ischemia
Stroke 33:319-320, van Gijn,J., 2002
Plasma Exchange for Severe Attacks of CNS: Demyelination: Predictors of Response
Neurol 58:143-146, Keegan,M.,et al, 2002
Subtherapeutic Free Phenytoin Levels Following Fosphenytoin Therapy in Status Epilepticus
Neurol 58:147-148, Koul,R. &Deleu,D., 2002
Thunderclap Headache
JNNP 72:6-11, Dodick,D.W., 2002
Discontinuing Antiepileptic Drugs in Patients who are Seizure Free on Monotherapy
JNNP 72:22-25,5, Specchio,L.M.,et al, 2002
Almotriptan (AXERT) and Frovatriptan (FROVA) for Migraine
The Medical Letter 44:19-20, , 2002
The Safety of Triptans in the Treatment of Patients with Migraine
Am J Med 112:135-140, Jamieson,D.G., 2002